Organ Shortages, Stem-Cell Discoveries and Xenotransplantation To Be Highlighted At International Transplantation Meeting

May 10, 2000, 01:00 ET from American Society of Transplant Surgeons from ,Americans Society of

    CHICAGO, May 10 /PRNewswire/ -- Over 2000 medical professionals from 50
 countries will converge on the Windy City to discuss scientific advances and
 policy trends in the field of transplantation. Called TRANSPLANT 2000, the
 meeting is the first partnership of The American Society of Transplant
 Surgeons (ASTS), the American Society of Transplantation (AST) and their
 memberships of physicians, surgeons, scientists, nurses, organ procurement
 personnel and pharmacists.
     Clinicians and researchers will present nearly 1,200 findings on a wide
 variety of issues including: pediatric transplantation; organ shortages;
 emerging technologies; new surgical techniques; status of immunosuppression;
 stem-cell discoveries; progress in transplant tolerance, infections and
 complications; as well as advances in xenotransplantation and immunobiology.
     TRANSPLANT 2000 will feature major developments of interest to the public
 as well as to medical professionals. Among them are:
 
     Mandatory Liver Sharing Benefits Sickest at Expense of Others: Increasing
 the distribution area for donated organs cut waiting time for acute cases, but
 likely at the expense of healthier patients on the waiting list. (Abstract #3,
 Embargoed for release Sunday, May 14, 2:00 pm CST)
 
     New Test Predicts Rejection in Heart and Liver Transplants: A study with
 heart recipients and liver recipients suggests doctors may be able to predict
 organ rejection days or even weeks before symptoms appear. (Abstract #358,
 Embargoed for release Monday, May 15, 11:00 am CST)
 
     Blood-Pressure Drug Reduces Transplant-Related Cancers in Mice: An animal
 study shows common anti-hypertensive drugs lower the number of tumor growths
 associated with two immunosuppressive drugs that many transplant patients must
 take for life. (Abstract #1075, Embargoed for release Tuesday, May 16 noon
 CST)
 
     Children with Live-Donor Livers Grow Better: A successful liver transplant
 from a living related donor rather than a cadaver helps juvenile recipients
 grow significantly better. (Abstract #1102, Embargoed for release Wednesday,
 May 17, 9 am CST)
 
     Diabetics Need No Insulin after Islet Transplantation: A Canadian research
 team has developed a protocol demonstrated in eight patients with type 1
 diabetes who need neither insulin nor steroid immunosuppressives after
 pancreatic islet transplantation. (Abstract #1105, Embargoed for release
 Wednesday, May 17, 9 am CST)
 
 

SOURCE American Society of Transplant Surgeons; Americans Society of
    CHICAGO, May 10 /PRNewswire/ -- Over 2000 medical professionals from 50
 countries will converge on the Windy City to discuss scientific advances and
 policy trends in the field of transplantation. Called TRANSPLANT 2000, the
 meeting is the first partnership of The American Society of Transplant
 Surgeons (ASTS), the American Society of Transplantation (AST) and their
 memberships of physicians, surgeons, scientists, nurses, organ procurement
 personnel and pharmacists.
     Clinicians and researchers will present nearly 1,200 findings on a wide
 variety of issues including: pediatric transplantation; organ shortages;
 emerging technologies; new surgical techniques; status of immunosuppression;
 stem-cell discoveries; progress in transplant tolerance, infections and
 complications; as well as advances in xenotransplantation and immunobiology.
     TRANSPLANT 2000 will feature major developments of interest to the public
 as well as to medical professionals. Among them are:
 
     Mandatory Liver Sharing Benefits Sickest at Expense of Others: Increasing
 the distribution area for donated organs cut waiting time for acute cases, but
 likely at the expense of healthier patients on the waiting list. (Abstract #3,
 Embargoed for release Sunday, May 14, 2:00 pm CST)
 
     New Test Predicts Rejection in Heart and Liver Transplants: A study with
 heart recipients and liver recipients suggests doctors may be able to predict
 organ rejection days or even weeks before symptoms appear. (Abstract #358,
 Embargoed for release Monday, May 15, 11:00 am CST)
 
     Blood-Pressure Drug Reduces Transplant-Related Cancers in Mice: An animal
 study shows common anti-hypertensive drugs lower the number of tumor growths
 associated with two immunosuppressive drugs that many transplant patients must
 take for life. (Abstract #1075, Embargoed for release Tuesday, May 16 noon
 CST)
 
     Children with Live-Donor Livers Grow Better: A successful liver transplant
 from a living related donor rather than a cadaver helps juvenile recipients
 grow significantly better. (Abstract #1102, Embargoed for release Wednesday,
 May 17, 9 am CST)
 
     Diabetics Need No Insulin after Islet Transplantation: A Canadian research
 team has developed a protocol demonstrated in eight patients with type 1
 diabetes who need neither insulin nor steroid immunosuppressives after
 pancreatic islet transplantation. (Abstract #1105, Embargoed for release
 Wednesday, May 17, 9 am CST)
 
 SOURCE  American Society of Transplant Surgeons; Americans Society of